Global Urological Cancer Market to Grow at a Compound Annual Growth Rate (CAGR) of 10.39% from $17.9 Billion in 2015 to $35.9 Billion in 2022: MarketResearchReports.Biz
Urological cancers are thought to account for 19.5% of global cancer prevalence, with kidney, prostate, testicular and bladder cancer - the key indications covered in this report - accounting for the majority of that figure. Urological cancers affect the male and female urinary tract and the male reproductive organs. Prostate cancer is the most prevalent of these malignancies.
View full press release